| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP & CFO
1 company
Mark Leonard Singleton is SVP & CFO at BVS. Mark Leonard Singleton's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.9M at current prices.
Our model assigns Mark Leonard Singleton a below-average insider score of 46/100, based on 9 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -24.8%.
The BVS filings lean toward selling, a net 65,142 shares.
Mark Leonard Singleton has 25 Form 4 filings on record from April 2022 to April 2026, all as SVP & CFO at Bioventus (BVS), 2022–2026.
The 38 reported transactions were 13 option exercises, 12 option or other derivative awards, 9 open-market sales and 4 tax withholdings.
Counted by filing, the open-market trades come to no purchases and 9 sales worth about $450K.
The largest open-market sale was 10,733 shares of BVS at an average $10.53 on December 23, 2024, about $113K. Twelve months later BVS was down 29%.
7 of the 8 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | BVS Bioventus Inc. | SVP & CFO | Sell10b5-1 | 3,875 | $7.57 | $29,333.75 | -2.7% | -1.2% | +21.1% | |
| Mar 24, 2025 | BVS Bioventus Inc. | SVP & CFO | Sell10b5-1 | 5,479 | $9.79 | $53,639.41 | -4.0% | -32.9% | -5.9% | |
| Feb 18, 2025 | BVS Bioventus Inc. | SVP & CFO | Sell10b5-1 | 6,498 | $10.19 | $66,214.62 | -5.2% | -33.3% | -18.3% | |
| Dec 23, 2024 | BVS Bioventus Inc. | SVP & CFO | Sell10b5-1 | 10,733 | $10.53 | $113,018.49 | -9.3% | -8.7% | -29.3% | |
| Jun 21, 2024 | BVS Bioventus Inc. | SVP & CFO | Sell10b5-1 | 9,219 | $5.57 | $51,349.83 | -9.8% | +104.4% | +15.5% | |
| Jun 17, 2024 | BVS Bioventus Inc. | SVP & CFO | Sell10b5-1 | 13,753 | $5.84 | $80,317.52 | -17.9% | +86.2% | +6.9% | |
| Apr 11, 2024 | BVS Bioventus Inc. | SVP & CFO | Sell10b5-1 | 4,000 | $4.75 | $19,000.00 | -10.3% | +22.5% | +55.5% | |
| Mar 22, 2024 | BVS Bioventus Inc. | SVP & CFO | Sale+OE | 5,541 | $5.39 | $29,852.69 | -17.8% | +2.9% | +77.4% | |
| Mar 24, 2023 | BVS Bioventus Inc. | SVP & CFO | Sell | 6,044 | $1.27 | $7,675.88 | -32.5% | +129.0% | +315.3% |